LifeStance Health Group, Inc. LFST
13.37 USD +0.11 (+0.83%)
At closeNov 3, 2026, 7:35 PM EST
13.44 +0.07 +0.52%
After hours · Nov 3, 7:35 PM ET
13.28 Day range 13.69
4.81 52-week range 13.64
- YTD
- +89.91%
- 1 year
- +171.75%
Financial health
Altman Z-Score
4.72 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
8 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 2
- Return on Assets 3
- Debt / Equity 3
- P/E 1
- P/B 3
Valuation
P/E 235×
FY 2019 5y median -9.1× FY 2025
P/S 1.9×
FY 2019 5y median 2.2× FY 2025
P/B 1.8×
FY 2019 5y median 1.9× FY 2025
P/FCF 24.7×
FY 2019 5y median -36.7× FY 2025
EV/EBITDA 33.8×
FY 2019 5y median -13.0× FY 2025
EV/Sales 1.9×
FY 2019 5y median 2.5× FY 2025
FCF Yield 4.0%
FY 2019 5y median -1.5% FY 2025
Profitability
Gross Margin 32.4%
FY 2019 5y median 30.2% FY 2025
Operating Margin 1.7%
FY 2019 5y median -17.9% FY 2025
Net Margin 0.7%
FY 2019 5y median -17.6% FY 2025
ROE 0.6%
FY 2019 5y median -13.0% FY 2025
ROIC 0.9%
FY 2019 5y median -8.7% FY 2025
ROA 0.4%
FY 2019 5y median -8.8% FY 2025
Growth (YoY)
Revenue 13.9%
FY 2019 FY 2025
Operating Income 176.4%
FY 2019 FY 2025
EPS (diluted) 113.3%
FY 2019 FY 2025
Free Cash Flow 28.4%
FY 2019 FY 2025
Financial Health
Current Ratio 1.7×
FY 2019 5y median 1.4× FY 2025
Quick Ratio 1.7×
FY 2019 5y median 1.4× FY 2025
Debt / Equity 0.1×
FY 2019 5y median 0.3× FY 2025
Net Debt / EBITDA -0.7×
FY 2019 5y median -0.7× FY 2025
Interest Coverage 2.1×
FY 2019 5y median -7.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31